Ilina brings 10+ years of experience in life sciences strategy consulting. Her expertise includes R&D portfolio planning, L,M&A opportunity identification, prioritization and valuation, and commercial and market access strategies for products throughout their lifecycle. Her experience has spanned an array of therapeutic areas, with a particular focus in oncology (drug and diagnostics), rare diseases, immune/inflammatory disorders, and renal disorders. She has served a range of healthcare clients including top global pharmaceutical companies, smaller biotech companies, and diagnostic companies.

Prior to joining Huron, Ilina spent 8 years at The Frankel Group. She also has experience working as a consultant at Quintiles Transnational in their Strategic Research Services group, and as a Research Associate at the National Cancer Institute.